Open AccessS116: LONG‐TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION‐DEPENDENT ALPHA‐ OR BETA‐THALASSEMIA
Author(s) -
Kuo K,
Layton D,
Lal A,
AlSamkari H,
Bhatia J,
Kosinski P,
Tong B,
Lynch M,
Uhlig K,
Vichinsky E
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821432.34545.49
Subject(s) - medicine , hemolysis , thalassemia , ineffective erythropoiesis , adverse effect , erythropoiesis , pyruvate kinase , anemia , pyruvate kinase deficiency , gastroenterology , pharmacology , glycolysis , metabolism